American National Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $139K | Buy |
278
+9
| +3% | +$4.32K | 0.01% | 281 |
|
|
2026
Q1 | $132K | Sell |
269
-9
| -3% | -$4.88K | 0.01% | 272 |
|
|
2025
Q4 | $161K | Buy |
278
+16
| +6% | +$9.05K | 0.02% | 261 |
|
|
2025
Q3 | $127K | Buy |
262
+13
| +5% | +$6.05K | 0.01% | 269 |
|
|
2025
Q2 | $101K | Buy |
249
+106
| +74% | +$44.3K | 0.01% | 311 |
|
|
2025
Q1 | $71.2K | Buy |
143
+10
| +8% | +$5.42K | 0.01% | 302 |
|
|
2024
Q4 | $69.2K | Sell |
133
-138
| -51% | -$75.9K | 0.01% | 289 |
|
|
2024
Q3 | $168K | Sell |
271
-4
| -1% | -$2.37K | 0.02% | 216 |
|
|
2024
Q2 | $152K | Buy |
275
+28
| +11% | +$16K | 0.02% | 231 |
|
|
2024
Q1 | $144K | Sell |
247
-79
| -24% | -$44.3K | 0.02% | 225 |
|
|
2023
Q4 | $173K | Sell |
326
-213
| -40% | -$103K | 0.03% | 187 |
|
|
2023
Q3 | $273K | Buy |
539
+6
| +1% | +$3.2K | 0.05% | 148 |
|
|
2023
Q2 | $278K | Hold |
533
| – | – | 0.05% | 143 |
|
|
2023
Q1 | $307K | Hold |
533
| – | – | 0.06% | 135 |
|
|
2022
Q4 | $294K | Buy |
533
+204
| +62% | +$108K | 0.06% | 125 |
|
|
2022
Q3 | $167K | Buy |
329
+179
| +119% | +$100K | 0.04% | 127 |
|
|
2022
Q2 | $81K | Hold |
150
| – | – | 0.02% | 141 |
|
|
2022
Q1 | $89K | Buy |
150
+48
| +47% | +$27.6K | 0.02% | 153 |
|
|
2021
Q4 | $68K | Hold |
102
| – | – | 0.01% | 168 |
|
|
2021
Q3 | $58K | Sell |
102
-62
| -38% | -$34K | 0.01% | 149 |
|
|
2021
Q2 | $83K | Buy |
164
+64
| +64% | +$30.2K | 0.02% | 139 |
|
|
2021
Q1 | $46K | Hold |
100
| – | – | 0.01% | 146 |
|
|
2020
Q4 | $47K | Hold |
100
| – | – | 0.01% | 140 |
|
|
2020
Q3 | $44K | Hold |
100
| – | – | 0.01% | 139 |
|
|
2020
Q2 | $36K | Hold |
100
| – | – | 0.01% | 152 |
|
|
2020
Q1 | $28K | Hold |
100
| – | – | 0.01% | 145 |
|
|
2019
Q4 | $32K | Hold |
100
| – | – | 0.01% | 151 |
|
|
2019
Q3 | $29K | Buy |
+100
| New | +$28.6K | 0.01% | 139 |
|
|
2017
Q3 | – | Sell |
-55
| Closed | -$10K | – | 261 |
|
|
2017
Q2 | $10K | Hold |
55
| – | – | ﹤0.01% | 230 |
|
|
2017
Q1 | $8K | Sell |
55
-5
| -8% | -$764 | ﹤0.01% | 244 |
|
|
2016
Q4 | $8K | Buy |
+60
| New | +$8.85K | ﹤0.01% | 240 |
|
|
2015
Q4 | – | Sell |
-68
| Closed | -$8K | – | 249 |
|
|
2015
Q3 | $8K | Buy |
68
+18
| +36% | +$2.35K | ﹤0.01% | 212 |
|
|
2015
Q2 | $6K | Sell |
50
-993
| -95% | -$129K | ﹤0.01% | 245 |
|
|
2015
Q1 | $140K | Hold |
1,043
| – | – | 0.05% | 90 |
|
|
2014
Q4 | $131K | Sell |
1,043
-165
| -14% | -$20.1K | 0.05% | 96 |
|
|
2014
Q3 | $147K | Buy |
+1,208
| New | +$147K | 0.06% | 89 |
|
Other funds holding TMO
RG
ECSS
LT
ATO
QP
American National Bank & Trust's TMO Position: Q2 2026 in Review
American National Bank & Trust increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q2 2026, buying an estimated $4.32K and bringing the position to 278 shares worth $139K. The position accounts for 0.01% of the portfolio, ranked #281.
American National Bank & Trust first reported a position in TMO in Q3 2014 and has held it in 36 quarters since. The position peaked at $307K in Q1 2023. 971 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- American National Bank & Trust held 278 shares of Thermo Fisher Scientific worth $139K as of Q2 2026.
- American National Bank & Trust bought 9 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.32K.
- Thermo Fisher Scientific made up 0.01% of American National Bank & Trust's portfolio in Q2 2026, its #281 holding.
- American National Bank & Trust first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 36 quarters since.
- American National Bank & Trust's Thermo Fisher Scientific position peaked at $307K in Q1 2023.
- 971 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.